These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10095999)

  • 1. Islet transplantation: present and future perspectives.
    Kenyon NS; Ranuncoli A; Masetti M; Chatzipetrou M; Ricordi C
    Diabetes Metab Rev; 1998 Dec; 14(4):303-13. PubMed ID: 10095999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of immunosuppression on engraftment of pancreatic islets.
    Vallabhajosyula P; Hirakata A; Shimizu A; Okumi M; Tchipashvili V; Hong H; Yamada K; Sachs DH
    Transplantation; 2013 Aug; 96(4):372-8. PubMed ID: 23883972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.
    Contreras JL; Eckhoff DE; Cartner S; Bilbao G; Ricordi C; Neville DM; Thomas FT; Thomas JM
    Transplantation; 2000 Jan; 69(2):195-201. PubMed ID: 10670626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical islet transplantation at the University of Alberta--the Edmonton experience.
    Truong W; Lakey JR; Ryan EA; Shapiro AM
    Clin Transpl; 2005; ():153-72. PubMed ID: 17424733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.
    Nanji SA; Shapiro AM
    BioDrugs; 2004; 18(5):315-28. PubMed ID: 15377174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological aspects of pancreatic islet cell transplantation.
    Azzi J; Geara AS; El-Sayegh S; Abdi R
    Expert Rev Clin Immunol; 2010 Jan; 6(1):111-24. PubMed ID: 20383895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human islet transplantation: update.
    Boker A; Rothenberg L; Hernandez C; Kenyon NS; Ricordi C; Alejandro R
    World J Surg; 2001 Apr; 25(4):481-6. PubMed ID: 11344402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current indications and limits of pancreatic islet transplantation in diabetic nephropathy.
    Masetti M; Inverardi L; Ranuncoli A; Iaria G; Lupo F; Vizzardelli C; Kenyon NS; Alejandro R; Ricordi C
    J Nephrol; 1997; 10(5):245-52. PubMed ID: 9364315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
    Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
    Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
    Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
    Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of islets of Langerhans in patients with insulin-dependent diabetes mellitus.
    Alejandro R
    Scand J Gastroenterol Suppl; 1995; 208():125-8. PubMed ID: 7777792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet transplantation in type 1 diabetes: hype, hope and reality - a clinician's perspective.
    Zinger A; Leibowitz G
    Diabetes Metab Res Rev; 2014 Feb; 30(2):83-7. PubMed ID: 24123789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of pancreatic islet transplantation.
    Reffet S; Thivolet C
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):523-6. PubMed ID: 17130811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Islet transplantation in type I diabetes mellitus].
    Lehmann R; Pavlicek V; Spinas GA; Weber M
    Ther Umsch; 2005 Jul; 62(7):481-6. PubMed ID: 16075955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.
    Turgeon NA; Avila JG; Cano JA; Hutchinson JJ; Badell IR; Page AJ; Adams AB; Sears MH; Bowen PH; Kirk AD; Pearson TC; Larsen CP
    Am J Transplant; 2010 Sep; 10(9):2082-91. PubMed ID: 20883542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a specific immunosuppression for pancreas and islet grafts.
    Jindal RM; Dubernard JM
    Clin Transplant; 2000 Jun; 14(3):242-5. PubMed ID: 10831083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.